BioNTech ramps up vaccine production at another production plant in Germany

BioNTech ramps up vaccine production at another production plant in Germany German pharmaceutical company BioNTech, Pfizer's Covid-19 vaccine partner, has opened a new production facility in Marburg, Germany to ramp up production of their vaccines. By James Griffiths, Adam Renton, Kara Fox and Christopher Johnson, CNN CNN

German pharmaceutical company BioNTech, Pfizer's Covid-19 vaccine partner, has opened a new production facility in Marburg, Germany to ramp up production of their vaccines.

BioNTech is already producing its vaccine at its plant in Mainz, with other third party facilities in Germany also in production. A Pfizer facility in Puurs, Belgium as well as other Pfizer facilities in the US also produce the joint venture's vaccine.

Last year, BioNTech said the acquisition of the vaccine plant in Marburg -- from the pharmaceutical firm Novartis -- would allow it to produce tens of millions more vaccine doses a month.

Earlier this month, BioNTech said in a statement that it was planning to manufacture two billion doses of their vaccine in 2021, and would work towards increasing their deliveries to parties they had "we contractually committed to." ...